165 related articles for article (PubMed ID: 11383457)
1. [Molecular-genetic determinants of the neoplastic process and state-of-the-art treatment of patients with uterine leiomyoma].
Vikhliaeva EM
Vopr Onkol; 2001; 47(2):200-4. PubMed ID: 11383457
[TBL] [Abstract][Full Text] [Related]
2. Single nucleotide polymorphisms in the progesterone receptor gene and association with uterine leiomyoma tumor characteristics and disease risk.
Renner SP; Strick R; Fasching PA; Oeser S; Oppelt P; Mueller A; Beckmann MW; Strissel PL
Am J Obstet Gynecol; 2008 Dec; 199(6):648.e1-9. PubMed ID: 18691687
[TBL] [Abstract][Full Text] [Related]
3. The effects of the selective progesterone receptor modulator asoprisnil on the morphology of uterine tissues after 3 months treatment in patients with symptomatic uterine leiomyomata.
Williams AR; Critchley HO; Osei J; Ingamells S; Cameron IT; Han C; Chwalisz K
Hum Reprod; 2007 Jun; 22(6):1696-704. PubMed ID: 17339234
[TBL] [Abstract][Full Text] [Related]
4. Sex steroidal regulation of uterine leiomyoma growth and apoptosis.
Maruo T; Ohara N; Wang J; Matsuo H
Hum Reprod Update; 2004; 10(3):207-20. PubMed ID: 15140868
[TBL] [Abstract][Full Text] [Related]
5. Expression profile of the tumorigenic factors associated with tumor size and sex steroid hormone status in uterine leiomyomata.
Wei JJ; Chiriboga L; Mittal K
Fertil Steril; 2005 Aug; 84(2):474-84. PubMed ID: 16084893
[TBL] [Abstract][Full Text] [Related]
6. Identification of a sensitive period for developmental programming that increases risk for uterine leiomyoma in Eker rats.
Cook JD; Davis BJ; Goewey JA; Berry TD; Walker CL
Reprod Sci; 2007 Feb; 14(2):121-36. PubMed ID: 17636224
[TBL] [Abstract][Full Text] [Related]
7. [Effect of mifepristone on the expression of progesterone receptor messenger RNA and protein in uterine leiomyomata].
Sun M; Zhu G; Zhou L
Zhonghua Fu Chan Ke Za Zhi; 1998 Apr; 33(4):227-31. PubMed ID: 10682471
[TBL] [Abstract][Full Text] [Related]
8. [Genetics of uterine leiomyomata].
Pedeutour F; Ligon AH; Morton CC
Bull Cancer; 1999 Nov; 86(11):920-8. PubMed ID: 10586108
[TBL] [Abstract][Full Text] [Related]
9. A randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata.
Chwalisz K; Larsen L; Mattia-Goldberg C; Edmonds A; Elger W; Winkel CA
Fertil Steril; 2007 Jun; 87(6):1399-412. PubMed ID: 17307170
[TBL] [Abstract][Full Text] [Related]
10. Gene expression studies in leiomyomata: new directions for research.
Catherino W; Salama A; Potlog-Nahari C; Leppert P; Tsibris J; Segars J
Semin Reprod Med; 2004 May; 22(2):83-90. PubMed ID: 15164303
[TBL] [Abstract][Full Text] [Related]
11. [Effects of mifepristone on estrogen and progestin receptors in human uterine leiomyoma].
Wang H; Jin J
Zhonghua Fu Chan Ke Za Zhi; 2000 Feb; 35(2):79-81. PubMed ID: 11809103
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential for the selective progesterone receptor modulator asoprisnil in the treatment of leiomyomata.
Chwalisz K; DeManno D; Garg R; Larsen L; Mattia-Goldberg C; Stickler T
Semin Reprod Med; 2004 May; 22(2):113-9. PubMed ID: 15164306
[TBL] [Abstract][Full Text] [Related]
13. Genetics of uterine leiomyomata.
Ligon AH; Morton CC
Genes Chromosomes Cancer; 2000 Jul; 28(3):235-45. PubMed ID: 10862029
[TBL] [Abstract][Full Text] [Related]
14. Highlights from the 2008 SGI meeting.
Maduro MR
Reprod Sci; 2008 Apr; 15(4):333-4. PubMed ID: 18497340
[No Abstract] [Full Text] [Related]
15. Minimal interval defined on 7q in uterine leiomyoma.
Sell SM; Tullis C; Stracner D; Song CY; Gewin J
Cancer Genet Cytogenet; 2005 Feb; 157(1):67-9. PubMed ID: 15676150
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of early growth response-1 and its role in uterine leiomyoma growth.
Shozu M; Murakami K; Segawa T; Kasai T; Ishikawa H; Shinohara K; Okada M; Inoue M
Cancer Res; 2004 Jul; 64(13):4677-84. PubMed ID: 15231681
[TBL] [Abstract][Full Text] [Related]
17. Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas.
Palomba S; Orio F; Russo T; Falbo A; Cascella T; Doldo P; Nappi C; Lombardi G; Mastrantonio P; Zullo F
Hum Reprod; 2004 Jun; 19(6):1308-14. PubMed ID: 15117890
[TBL] [Abstract][Full Text] [Related]
18. Cellular senescence in usual type uterine leiomyoma.
Markowski DN; Helmke BM; Bullerdiek J
Fertil Steril; 2010 Nov; 94(6):e79; author reply e80. PubMed ID: 20850727
[No Abstract] [Full Text] [Related]
19. A comparative study of the effect of raloxifene and gosereline on uterine leiomyoma volume changes and estrogen receptor, progesterone receptor, bcl-2 and p53 expression immunohistochemically in premenopausal women.
Baytur YB; Ozbilgin K; Cilaker S; Lacin S; Kurtul O; Oruc S; Koyuncu FM
Eur J Obstet Gynecol Reprod Biol; 2007 Nov; 135(1):94-103. PubMed ID: 16973256
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis in human uterine leiomyomas.
Martel KM; Ko AC; Christman GM; Stribley JM
Semin Reprod Med; 2004 May; 22(2):91-103. PubMed ID: 15164304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
